Julia Dreisbach

5PUBLICATIONS
30CO-AUTHORS
MycologyPharmacogenomicsMicrobial geneticsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 08, 2026
Modeling Treatment Response in Tuberculosis Early Bactericidal Activity Trials.

|Aug 20, 2025
First-in-human study of the benzothiazinone and DprE1 inhibitor BTZ-043, a novel drug candidate for the treatment of Tuberculosis.

Wandini Lutchmun, Norbert Heinrich, Elin M Svensson

|Mar 28, 2025
Population pharmacokinetics and exposure-response relationship of the antituberculosis drug BTZ-043.

Simon E Koele, Norbert Heinrich, Veronique R De Jager

|Feb 17, 2025
Translational Modeling of BTZ-043 to Predict Phase 2A Efficacy and Evaluate Drug-Drug Interactions With Bedaquiline, Pretomanid, and Linezolid in Murine Models.

Bernard Ngara, Lorenzo Flori, Rob Christiaan van Wijk

|Jan 18, 2025
The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis.

Andreas Römpp, Axel Treu, Julia Kokesch-Himmelreich

Pageof 1

Frequent Collaborators

3 joint publications

Michael Hoelscher

2 joint publications

Eric L Nuermberger

2 joint publications

Kerstin Walter

2 joint publications

Simon E Koele